BMO Capital Upgrades Genmab A/S (GMAB) to Outperform 'On Improved Outlook ex-Darzalex, Pipeline Optionality'

February 23, 2024 5:06 AM EST Send to a Friend
(Updated - February 23, 2024 5:07 AM EST)

BMO Capital analyst Etzer Darout upgraded Genmab A/S (NASDAQ: GMAB) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login